TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial-mesenchymal transition and metastasis in liver cancer

Oncogene. 2019 Jan;38(4):518-532. doi: 10.1038/s41388-018-0457-z. Epub 2018 Aug 28.

Abstract

Metastasis is the main cause of cancer mortality. However, the triggering mechanisms and regulation of epithelial-mesenchymal transition (EMT) factors in the commitment of metastasis have not been well characterized. Spermatogenic Zip 1 (SPZ1) acts as a proto-oncogene and an upstream regulator of EMT during tumorigenesis. Here we report that the HIV-1 Tat-interacting protein 60 kDa (Tip60) acetyltransferase mediates acetylation at lysine residues of SPZ1 at positions 369 and 374, and of TWIST1 at positions 73 and 76, which are required for SPZ1-TWIST1 complex formation and cancer cell migration in vitro and in vivo. Ectopic SPZ1 and TWIST1 expression, but not that of TWIST1 alone, enhanced vascular endothelial growth factor (VEGF) expression via the recruitment of bromodomain-containing protein 4 (BRD4), thus enhancing RNA-Pol II-dependent transcription and inducing metastasis. Neutralization of VEGF using humanized monoclonal antibodies such as Avastin, effectively abrogated the EMT and oncogenesis induced by the acetylated SPZ1-TWIST1 complex. Our findings highlight the importance of acetylation signaling in the SPZ1-TWIST1-BRD4 axis in the mediation of EMT and its regulation during tumor initiation and metastasis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / physiology*
  • Bevacizumab / pharmacology
  • Bevacizumab / therapeutic use
  • Carcinogenesis
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Epithelial-Mesenchymal Transition / physiology*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • Liver Neoplasms, Experimental / blood supply
  • Liver Neoplasms, Experimental / drug therapy
  • Liver Neoplasms, Experimental / genetics
  • Lysine Acetyltransferase 5 / physiology*
  • Mice
  • Mice, Nude
  • Mice, Transgenic
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Proteins / physiology*
  • Neovascularization, Pathologic / metabolism
  • Nuclear Proteins / physiology*
  • Protein Interaction Mapping
  • Protein Processing, Post-Translational*
  • Proto-Oncogene Mas
  • Signal Transduction
  • Sorafenib / pharmacology
  • Sorafenib / therapeutic use
  • Transcription Factors / physiology*
  • Twist-Related Protein 1 / physiology*
  • Vascular Endothelial Growth Factor A / biosynthesis
  • Vascular Endothelial Growth Factor A / genetics
  • Xenograft Model Antitumor Assays

Substances

  • BRD4 protein, human
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Cell Cycle Proteins
  • MAS1 protein, human
  • Neoplasm Proteins
  • Nuclear Proteins
  • Proto-Oncogene Mas
  • SPZ1 protein, human
  • TWIST1 protein, human
  • Transcription Factors
  • Twist-Related Protein 1
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Sorafenib
  • KAT5 protein, human
  • Lysine Acetyltransferase 5